[1]
Y. Wang, S. Qian, and K. Li, “Research Progress of the Treatment of PD-1 Immune CheckpointInhibitors in Oral Squamous Cell Carcinoma”, Jour. of oncol. res., vol. 2, no. 2, pp. 9–15, Jul. 2020.